Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetazidine in Diabetic Peripheral Neuropathy
NCT07794475Phase 2Recruiting
- Sponsor
- Sara Refaat Azab Metry
- Start
- Aug 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of trimetazidine in diabetic peripheral neuropathy (DPN), sponsored by Sara Refaat Azab Metry. Started Aug 2026; status: recruiting.
02
Drugs
trimetazidine
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT07794475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07794475.